Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels?
David J Maron
Correspondence Vanderbilt Page Campbell Heart Institute, 2311 Pierce Avenue, Nashville, TN 37232, USA
Email david.maron@vanderbilt.edu
This article has no abstract so we have provided the first paragraph of the full text.
Clinicians frequently face the question of how to begin pharmacologic therapy in patients with CHD and associated low HDL and LDL levels, especially if the LDL concentration falls below the threshold for LDL-lowering drug therapy according to current guidelines. Should one focus on raising HDL or on lowering LDL?
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
